Health Trials

About this trial

This is a 10-year, longitudinal, observational study of patients with NAFLD/NASH designed to specifically address important clinical questions that remain incompletely answered from registration trials. In addition to the study database, the biospecimen repository will also be included so that translational studies of genomics and biomarkers of response may be performed.

Eligibility criteria

Qualifiers

Males or females aged 18 and older;

Adults being managed or treated for NAFL or NASH;

Be able to communicate meaningfully with the Investigator and be legally competent to provide written informed consent.

Disqualifiers

Incompetent to understand and/or sign the informed consent;

Ethanol consumption exceeding more than 14 standard beverages per week for males and more than 7 standard beverages per week for female;

Causes for secondary hepatic fat accumulation such as significant alcohol consumption, medications, Wilson's disease, viral infections, starvation or parenteral nutrition, among others, and conditions associated with microvesicular steatosis

Diagnosis of liver cirrhosis and/or hepatocellular carcinoma;

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

1
Humanity and Health Medical Centre00852, Hong Kong Hong Kong

Sponsors and collaborators

Humanity and Health Research Centre

Lead sponsor

Source ClinicalTrials.gov